The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Psychotherapy and Psychosomatics

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000447034PMID 27508501
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New targets for rapid antidepressant action.

  2017cited by this paper
• Use of psychotropic drugs during pregnancy and breast‐feeding

  2016cited by this paper
• Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma.

  2016cited by this paper
• Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review

  2016cited by this paper
• Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database

  2016cited by this paper
• Suicide and suicidal behaviour.

  2016cited by this paper
• Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.

  2016cited by this paper
• Depression and Reduced Bone Mineral Density at the Hip and Lumbar Spine: A Comparative Meta-Analysis of Studies in Adults 60 Years and Older

  2016cited by this paper
• Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports

  2016cited by this paper
• Suicides and Suicide Attempts during Long-Term Treatment with Antidepressants: A Meta-Analysis of 29 Placebo-Controlled Studies Including 6,934 Patients with Major Depressive Disorder

  2016cited by this paper
• Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications

  2016cited by this paper
• Antidepressants and, suicide and self-injury: Causal or casual association?

  2016cited by this paper
• Depression and Disturbed Bone Metabolism: A Narrative Review of the Epidemiological Findings and Postulated Mechanisms.

  2016cited by this paper
• Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications

  2016cited by this paper
• Cognitive remission: a novel objective for the treatment of major depression?

  2016cited by this paper
• Antidepressants are associated with hospital admitted intracranial bleeds in people taking other medication associated with bleeding

  2016cited by this paper
• Is increased antidepressant exposure a contributory factor to the obesity pandemic?

  2016cited by this paper
• The Psychosomatic Factor in Clinical Practice. 23rd World Congress on Psychosomatic Medicine, Glasgow, August 20-22, 2015: Abstracts

  2015cited by this paper
• A systematic review of agomelatine-induced liver injury

  2015cited by this paper
• New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal

  2015cited by this paper
• The safety of serotonin–noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review

  2015cited by this paper
• Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology

  2015cited by this paper
• Diagnostic accuracy and adequacy of treatment of depressive and anxiety disorders: A comparison of primary care and specialized care patients.

  2015cited by this paper
• Sexual side-effects of antidepressant and antipsychotic drugs

  2015cited by this paper
• A review of the management of antidepressant discontinuation symptoms

  2015cited by this paper
• The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature.

  2015cited by this paper
• Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder

  2015cited by this paper
• Levomilnacipran for the treatment of major depressive disorder: a review

  2015cited by this paper
• Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review

  2015cited by this paper
• Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort.

  2015cited by this paper
• Prescriber's Guide to Using 3 New Antidepressants: Vilazodone, Levomilnacipran, Vortioxetine

  2015cited by this paper
• Extrapyramidal Reactions Associated With Serotonergic Antidepressants

  2015cited by this paper
• Iatrogenic comorbidity in mental health

  2015cited by this paper
• Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis.

  2015cited by this paper
• From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings

  2015cited by this paper
• Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding

  2015cited by this paper
• Placental Transfer of Antidepressant Medications: Implications for Postnatal Adaptation Syndrome

  2015cited by this paper
• Elevated Rest Heart Rate in Psychiatric Patients and Different Effects of Psychotropic Medication

  2015cited by this paper
• Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design

  2015cited by this paper
• Risk of angle-closure glaucoma with bupropion and topiramate.

  2015cited by this paper
• Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants

  2015cited by this paper
• Inconsistent Portrayal of Medication Dependence, Withdrawal and Discontinuation Symptoms in Treatment Guidelines for Anxiety Disorders

  2015cited by this paper
• Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design

  2015cited by this paper
• Long-Term Use of Selective Serotonin Reuptake Inhibitors and Risk of Glaucoma in Depression Patients

  2015cited by this paper
• Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

  2015cited by this paper
• The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis

  2015cited by this paper
• The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

  2015cited by this paper
• Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review

  2015cited by this paper
• Use of psychotropic drugs during pregnancy and breast‐feeding

  2015cited by this paper
• Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review.

  2015cited by this paper
• Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports

  2015cited by this paper
• Drug-Induced Urinary Incontinence

  2015cited by this paper
• The status of sleep abnormalities as a diagnostic test for major depressive disorder.

  2014cited by this paper
• Risk of suicidal behavior with antidepressants in bipolar and unipolar disorders.

  2014cited by this paper
• Dermatologic side effects of psychotropic medications.

  2014cited by this paper
• The FDA warning on antidepressants and suicidality--why the controversy?

  2014cited by this paper
• Mixed Depression: Clinical Features and Predictors of Its Onset Associated with Antidepressant Use

  2014cited by this paper
• Antidepressant dose, age, and the risk of deliberate self-harm.

  2014cited by this paper
• Rational Use of Antidepressant Drugs

  2014cited by this paper
• Antidepressant-induced liver injury: a review for clinicians.

  2014cited by this paper
• Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation.

  2014cited by this paper
• Serotonin syndrome.

  2014cited by this paper
• Sexual dysfunction associated with major depressive disorder and antidepressant treatment

  2014cited by this paper
• Persistent Postwithdrawal Disorders Induced by Paroxetine, a Selective Serotonin Reuptake Inhibitor, and Treated with Specific Cognitive Behavioral Therapy

  2014cited by this paper
• Effects of depression, anxiety, comorbidity, and antidepressants on resting-state heart rate and its variability: an ELSA-Brasil cohort baseline study.

  2014cited by this paper
• Euprolactinemic galactorrhea with escitalopram.

  2014cited by this paper
• New insights on the antidepressant discontinuation syndrome

  2014cited by this paper
• Major depressive disorder in breast cancer: a critical systematic review of pharmacological and psychotherapeutic clinical trials.

  2014cited by this paper
• The Clinical Inadequacy of Evidence-Based Medicine and the Need for a Conceptual Framework Based on Clinical Judgment

  2014cited by this paper
• Noncontinuous use of antidepressant in adults with major depressive disorders – a retrospective cohort study

  2014cited by this paper
• Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis

  2014cited by this paper
• Risk of Upper Gastrointestinal Bleeding With Selective Serotonin Reuptake Inhibitors With or Without Concurrent NonSteroidal Anti-Inflammatory Use: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Antidepressants and Sexual Dysfunction: Mechanisms and Clinical Implications

  2014cited by this paper
• Use of antidepressants and statins and short-term risk of new-onset diabetes among high risk adults.

  2014cited by this paper
• Antidepressants strongly influence the relationship between depression and heart rate variability: findings from The Irish Longitudinal Study on Ageing (TILDA)

  2014cited by this paper
• Psychotropic-induced hyperprolactinemia: a clinical review.

  2014cited by this paper
• Antidepressants and the risk of hyponatremia: a class-by-class review of literature.

  2014cited by this paper
• Antidepressant-induced sexual dysfunction in men.

  2014cited by this paper
• Selective serotonin reuptake inhibitor use and increased risk of cataract surgery: a population-based, case-control study.

  2014cited by this paper
• Idiosyncratic drug-induced liver injury: an update on the 2007 overview

  2014cited by this paper
• Factors predicting adherence to antidepressant treatment

  2014cited by this paper
• Bupropion in the depression-related sexual dysfunction: a systematic review.

  2014cited by this paper
• Comparative Efficacy and Risk of Harms of Immediate- versus Extended-Release Second-Generation Antidepressants: A Systematic Review with Network Meta-Analysis

  2014cited by this paper
• Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis

  2014cited by this paper
• An overview of vortioxetine.

  2014cited by this paper
• Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding.

  2014cited by this paper
• Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults

  2013cited by this paper
• What is the association between quality of treatment for depression and patient outcomes? A cohort study of adults consulting in primary care.

  2013cited by this paper
• High lipophilicity and high daily dose of oral medications are associated with significant risk for drug‐induced liver injury

  2013cited by this paper
• A review of the adverse effects and safety of noradrenergic antidepressants

  2013cited by this paper
• The cardiovascular safety profile of escitalopram.

  2013cited by this paper
• A Comparison of the Risk of QT Prolongation Among SSRIs

  2013cited by this paper
• Antidepressant use and new‐onset diabetes: a systematic review and meta‐analysis

  2013cited by this paper
• Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis

  2013cited by this paper
• The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis.

  2013cited by this paper
• A new logical insight and putative mechanism behind fluoxetine-induced amenorrhea, hyperprolactinemia and galactorrhea in a case series

  2013cited by this paper
• Excessive Mood Elevation and Behavioral Activation with Antidepressant Treatment of Juvenile Depressive and Anxiety Disorders: A Systematic Review

  2013cited by this paper
• Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States

  2013cited by this paper
• Antidepressants from a public health perspective: re‐examining effectiveness, suicide, and carcinogenicity

  2013cited by this paper
• QTc prolongation, torsades de pointes, and psychotropic medications.

  2013cited by this paper

• Roudoukou-Suanzaoren Ameliorates Chronic Restraint-Induced Anxiety- and Depression-Like Behaviors in Mice via the Gut-Brain Axis.

  2026cites this paper
• Lifestyle physical activity coaching in outpatients with major depressive disorder (PACOUTPAT): study protocol for a randomized controlled trial on physical activity, depression, and quality of life.

  2026cites this paper
• Psychotropic medication use and risks of kidney injury and fall-related events: a propensity score–matched cohort study

  2026cites this paper
• Genotoxicity and DNA Damage in Long-Term SSRI Therapy: A Review Across SSRIs With Citalopram as a Case Study.

  2026cites this paper
• Male sexual dysfunction associated with selective serotonin reuptake inhibitors (SSRIs): A pharmacovigilance disproportionality analysis of FAERS data.

  2026cites this paper
• Lifestyle Interventions for Major Depressive Disorder (MDD): An Expert Consensus Statement From the American College of Lifestyle Medicine.

  2026cites this paper
• Factors Associated with Perinatal Depression and Anxiety Among Pregnant and Postpartum Women: A Cross-Sectional Study Based on Questionnaire Data.

  2026cites this paper
• The evolution of SSRI research: trajectories of knowledge domains across four decades.

  2026cites this paper
• Chronicity moderates the impact of severity on central executive-default mode network functional interactions in depression.

  2026cites this paper
• Mechanistic insights into the antidepressant potential of plant-derived flavonoids: A preclinical review.

  2025cites this paper
• The efficacy of vortioxetine in the acute treatment of major depressive disorder: A systematic review and meta-analysis

  2025cites this paper
• In Situ Recovery of Serotonin Synthesis by a Tryptophan Hydroxylase-Like Nanozyme for the Treatment of Depression.

  2025cites this paper
• Kai-Xin-San ameliorates fluoxetine-resistant depressive-like behaviors by modulating tryptophan-kynurenine metabolic homeostasis in a rodent model.

  2025cites this paper
• Vortioxetine’s cardiovascular profile as a relevant feature for the management of major depressive disorder in comorbidity with organic diseases

  2025cites this paper
• Bifidobacterium breve BB05 alleviates depressive symptoms in mice via the AKT/mTOR pathway

  2025cites this paper
• Global disproportionality analysis of anxiolytic medication-associated cardiovascular and motor impairment disorders, 1967-2024: An international pharmacovigilance database.

  2025cites this paper
• Neuroinflammation and Natural Antidepressants: Balancing Fire with Flora

  2025cites this paper
• PPARγ activation attenuates neonatal CRD-induced visceral pain sensitization and anxiety in male rats by alleviating oxidative stress

  2025cites this paper
• Evaluating the Therapeutic Effects of Bupropion in a Patient with Dravet Syndrome and a Unique SCN2A Mutation

  2025cites this paper
• Effectiveness and safety of traditional East Asian herbal medicine for major depressive disorder with anxiety: a systematic review and meta-analysis

  2025cites this paper
• Post-marketing safety surveillance of vortioxetine hydrobromide: a pharmacovigilance study leveraging FAERS database

  2025cites this paper
• A retrospective analysis of combined treatment with escitalopram and Naoan dropping pills treatment for depression

  2025cites this paper
• Optimising Weight Management Advice for Adults Prescribed Antidepressants: A Qualitative Interview Study of Experiences

  2025cites this paper
• Question: Which Antidepressants Would Be Safest to Use in an Elderly Patient, Currently Taking Bupropion, Experiencing Decreasing Renal Function?

  2025cites this paper
• Gastrointestinal adverse events associated with SNRIs: A FAERS-based pharmacovigilance study.

  2025cites this paper
• The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review

  2025cites this paper
• Public psychology and holistic approaches to prevention and treatment of depression

  2025cites this paper
• Depression-related innate immune genes and pan-cancer gene analysis and validation

  2025cites this paper
• Impact of Antidepressants on Weight Gain: Underlying Mechanisms and Mitigation Strategies

  2025cites this paper
• Research Trends on the Efficacy of Antidepressant Medications in Adults with Major Depressive Disorder

  2025cites this paper
• Three Decades of SSRI/SNRI Withdrawal Research: A Bibliometric and Science-Mapping Study

  2025cites this paper
• Antidepressant selection modifies survival in depression: A National Cohort Study Using NHANES 2005 - 2018 data.

  2025cites this paper
• Impact of preoperative antidepressant use on surgical and functional outcomes of robot assisted radical prostatectomy

  2025cites this paper
• Chrysin enhances serotonergic and noradrenergic neurotransmission associated with antidepressant effects: A pharmacological study

  2025cites this paper
• Artemisinin exerts antidepressant-like effects via activation of AKT and ERK signaling pathways

  2025cites this paper
• Advances in fNIRS-Based Brain Functional Assessment: Neural Mechanisms of Acupuncture Intervention in Depression

  2025cites this paper
• Simultaneous modulation of 5-HT6 and SERT by MM394: a dual-target ligand providing neuroprotection against amyloid-β toxicity, memory preservation, and alleviation of BPSD symptoms.

  2025cites this paper
• Comparative gastrointestinal effects of antidepressants for the acute treatment of adults with major depressive disorder: a network and dose‒response meta-analysis

  2025cites this paper
• Adverse Events of Eye Disorders Related to the Use of Vortioxetine: A Disproportionality Analysis

  2025cites this paper
• Adjunctive bilateral vs. unilateral or sham repetitive transcranial magnetic stimulation for major depressive disorder or bipolar depression: a meta-analysis of randomized controlled studies

  2025cites this paper
• Особенности терапевтического выбора антидепрессантов в кардиологической практике: обзор литературы

  2025cites this paper
• Use of vortioxetine in different neurological fields: a systematic review and future perspectives

  2025cites this paper
• Bambusa vulgaris Extract: A Potential Natural Biogenic Amine Neurotransmitters Modulator, COX-2 Inhibitor and Oxidative Species Suppressor for Managing Depression and Anxiety

  2025cites this paper
• The Assessment of the Safety Profile of Selective Serotonin Reuptake Inhibitors Versus Other Antidepressants: Drug–Drug Interaction Insights from EudraVigilance

  2025cites this paper
• From efficacy to adversity: understanding the side effects of antidepressants - systematic review.

  2025cites this paper
• Agomelatine Alleviates Depressive-like Behaviors by Suppressing Hippocampal Oxidative Stress in the Chronic Social Defeat Stress Model

  2025cites this paper
• Individual patient data meta-analysis of placebo-controlled trials of selective serotonin reuptake inhibitors submitted for regulatory approval in adult obsessive–compulsive disorder

  2025cites this paper
• Molecular Mechanisms Underlying Apple Extract Ameliorates Depression‐Incident Cognitive Dysfunction Based on Network Pharmacology

  2025cites this paper
• Obesity mediate associations between depression and wet overactive bladder: Results from 2005 to 2020 NHANES.

  2025cites this paper
• Psychic and Cognitive Impacts of Cardiovascular Disease: Evidence from an Observational Study and Comparison by a Systematic Literature Review

  2025cites this paper
• Neurological adverse events associated with antidepressants: a comprehensive 22-year analysis of the FDA adverse event reporting system

  2025cites this paper
• Bupropion, the atypical antidepressant used in smoke cessation: an in vitro study on its effects on human sperm function.

  2025cites this paper
• Role of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and Psychedelics in the Treatment of Major Depressive Disorder: A Perspective on Mechanistic Insight and Current Status.

  2025cites this paper
• Aberrant Tryptophan Metabolism Manipulates Osteochondral Homeostasis

  2025cites this paper
• Acupuncture for the anxiety and depression in Parkinson disease: A systematic review and network meta-analysis

  2025cites this paper
• Multi-omics analysis reveals the mechanism of action of Atractylodin against depression

  2025cites this paper
• Antidepressant effects of ershiwei roudoukou pills and its active ingredient Macelignan: Multiple mechanisms involving oxidative stress, neuroinflammation and synaptic plasticity

  2025cites this paper
• Efficacy of donepezil versus donepezil and trazodone in combination cognitive dysfunction in patients with dementia: a randomized controlled trial

  2025cites this paper
• Urinary retention caused by mirtazapine in a patient with geriatric depression: A case report

  2025cites this paper
• The effects of berberine on depressive symptoms: a systematic review and meta-analysis of preclinical studies

  2025cites this paper
• Off-Label Prescription of Benzodiazepines: A Retrospective Cohort Study of Prescribing Prevalence in Primary Care

  2025cites this paper
• Efficacy and safety of GW117 tablets in major depressive disorder: a randomised, double-blind, placebo-controlled, phase 2 dose-finding study

  2025cites this paper
• Psychotropic drugs: a practical guide for use in dermatology.

  2025cites this paper
• The Interplay of Cross‐Organ Immune Regulation in Inflammation and Cancer

  2025cites this paper
• Esketamine Monotherapy in Adults With Treatment-Resistant Depression

  2025cites this paper
• Effects of meeting exercise guidelines on depression and anxiety in multiple sclerosis – a systematic review and meta-analysis

  2025cites this paper
• From Network Prediction to Experimental Validation: Multi-Target Mechanisms of Artemisia absinthium L. Essential Oil (AAEO) Against Depression.

  2025cites this paper
• Genetic predisposition to unwanted side effects under antidepressants and antipsychotics: a molecular-genetic study of 902 patients over 6 weeks

  2025cites this paper
• Antidepressant mechanism of Xiaoyaosan: A perspective from energy metabolism of the brain and intestine.

  2025cites this paper
• A pharmacovigilance study of vortioxetine based on data from the FDA adverse event reporting system

  2025cites this paper
• Efficacy and safety of lower dose electroconvulsive therapy for major depression in adolescents with suicide ideation: A non-inferiority randomized controlled trial in China.

  2025cites this paper
• Discontinuing antidepressant medication: a qualitative evidence synthesis and logic model based on health professionals’ views

  2025cites this paper
• ARE CONVENTIONAL ANTIDEPRESSANTS ENOUGH? THE GUT MICROBIOME AND NANOCARRIER-BASED DELIVERY SYSTEMS AS FUTURE PROSPECTS FOR DEPRESSION TREATMENT.

  2025cites this paper
• The Effect of Antidepressant Use on Weight Loss After One Anastomosis Gastric Bypass: A Retrospective Cohort Study

  2025cites this paper
• Антидепрессанты в эпоху кардиометаболической пандемии: от кардиобезопасности к адипоцентричности

  2025cites this paper
• Sexual Dysfunction in Male Patients After Initiating Treatment with Antidepressants.

  2025cites this paper
• Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine

  2024cites this paper
• Preoperative management of medications for psychiatric disorders.

  2024cites this paper
• ProMENDA: an updated resource for proteomic and metabolomic characterization in depression

  2024cites this paper
• Assessing metabolic risk factors for psychiatric patients: An IT-supported task shift from physician to pharmacist

  2024cites this paper
• Alcohol Consumption Is a Coping Mechanism for Male Patients with Severe Anxiety Disorders Treated with Antidepressants Monotherapy

  2024cites this paper
• Adverse event profiles of drug-induced liver injury caused by antidepressant drugs: a disproportionality analysis

  2024cites this paper
• Early-relief effects of tetrahedral DNA nanostructures-assisted depression therapy via modulates hippocampal neurogenesis and neuroplasticity

  2024cites this paper
• Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method

  2024cites this paper
• Sexual Disorders in Females with Bipolar Disorder

  2024cites this paper
• Antidepressant-induced membrane trafficking regulates blood-brain barrier permeability

  2024cites this paper
• Healthy lifestyle and the risk of depression recurrence requiring hospitalisation and mortality among adults with pre-existing depression: a prospective cohort study

  2024cites this paper
• From gut to brain: understanding the role of microbiota in inflammatory bowel disease

  2024cites this paper
• Research status and trends of physical activity on depression or anxiety: a bibliometric analysis

  2024cites this paper
• Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When

  2024influential citation
• Association between eicosapentaenoic acid consumption and the risk of depressive symptoms in US adults: Analyses from NHANES 2005-2018.

  2024cites this paper
• Ligne directrice canadienne pour la prise en charge clinique de la consommation d’alcool à risque élevé et du trouble d’utilisation de l’alcool

  2024cites this paper
• Co-decoction of Lilii bulbus and Radix Rehmannia Recens and its key bioactive ingredient verbascoside inhibit neuroinflammation and intestinal permeability associated with chronic stress-induced depression via the gut microbiota-brain axis.

  2024cites this paper
• The risk of antidepressant-induced hyponatremia: A meta-analysis of antidepressant classes and compounds

  2024cites this paper
• Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?

  2024cites this paper
• Moderate Alcohol Consumption Increases the Risk of Clinical Relapse in Male Depressed Patients Treated with Serotonin-Norepinephrine Reuptake Inhibitors

  2024cites this paper
• Treatment-emergent sexual dysfunctions due to antidepressants: A primer on assessment and management strategies

  2024cites this paper
• Multichannel tDCS with Advanced Targeting for Major Depressive Disorder: A Tele-Supervised At-Home Pilot Study

  2024cites this paper
• Sildenafil, alone and in combination with imipramine or escitalopram, display antidepressant-like effects in an adrenocorticotropic hormone-induced (ACTH) rodent model of treatment-resistant depression.

  2024cites this paper
• Evaluation of selective-serotonin reuptake inhibitors and anti-androgens to manage sexual compulsivity in individuals serving a custodial sentence for a sexual offence

  2024cites this paper